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Abstract The pore-forming colicins N and A require the porin,
OmpF, in order to translocate across the outer membrane of
Escherichia coli. We investigated the hypothesis that in vivo,
colicins N and A may traverse the outer membrane through the
OmpF channel. In order to accommodate a polypeptide in the
pore, the mid-channel constriction loop of OmpF, L3, would need
to undergo a conformational change. We used five OmpF cystine
mutants, which fix L3 in the conformation determined by X-ray
crystallography, to investigate L3 movement during colicin
activity in vivo. Sensitivity to colicins N and A of E. coli cells
expressing these OmpF cystine mutants was determined using
cell survival and in vivo potassium efflux and fluorescence assays.
Results indicate that gross movement of L3 is not required for
colicin N or A activity and that neither of these colicins crosses
the outer membrane of E. coli through the lumen of the OmpF
pore.
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1. Introduction
The non-selective, outer membrane porins of Escherichia
coli, OmpC, OmpF and PhoE, allow the passive di¡usion of
small hydrophilic molecules with a molecular weight of less
than 600 Da, into and out of the periplasm. They are cur-
rently the only transmembrane channels with known high
resolution 3D structures [1^7]. They all form trimers and
the non-selective porins, such as E. coli OmpF, consist of
16-stranded L-barrels with each monomer forming a pore.
Within each pore a long polypeptide loop (L3) runs along
one side of the barrel wall and narrows the pore to create
the ‘eyelet’ or ‘constriction’ region. As well as being a general
di¡usion pore, OmpF also serves as a cell-surface receptor for
phages and colicins A and N [8,9].
Colicins are plasmid-encoded bacteriocins produced by E.
coli which kill closely related bacteria. The toxic action of
colicins occurs in three stages associated with three separate
structural domains: (1) receptor recognition and binding (cen-
tral R-domain); (2) translocation across the cell envelope (N-
terminal T-domain); (3) lethal action in the form of either
pore formation in the cytoplasmic membrane or nuclease ac-
tivity in the cytoplasm (C-terminal P-domain) (for reviews see
[10^12]). Colicins N and A are pore-forming colicins belong-
ing to the A group of colicins [13] which require the tol
QRAB proteins for translocation across the outer membrane
[14]. Although they both require OmpF as receptor for full
activity in vivo [9,15,16], colicin N has also been shown to
bind to the related porins OmpC and PhoE with similar bind-
ing a⁄nities in vitro [17]. Nevertheless cells expressing only
PhoE/OmpC show greatly reduced sensitivities to colicin N
[16,18] and hence OmpF must play a role in later stages of
translocation.
Colicin A requires an additional receptor, BtuB, but in the
presence of low salt concentrations (10 mM phosphate bu¡er),
this requirement can be by-passed (receptor by-pass condi-
tions) [18,19]. However, under these conditions, neither colicin
N or A can by-pass its requirement for OmpF (although col-
icin A can substitute the closely related OmpC) in what is
likely to be the translocation step. Hence the porins are a
part of the translocation pathway across the outer membrane.
Other colicins which do not require OmpF use related pro-
teins, e.g. TolC (colicin E1) [20,21], Tsx (colicin K) [22,23] and
FepA (colicin B) [24,25], which are all L-barrel outer-mem-
brane proteins with channel forming activity. The bacteriocin
(pesticin) which is active against the bubonic plague agent
Yersinia pestis also requires a related iron uptake receptor
[26].
It is thought that the interaction with their receptors indu-
ces a conformational change or unfolding in the colicins, re-
sulting in the entry of the colicin into the translocation ma-
chinery composed of the tolQRAB proteins. [27^29]. Studies
on colicin A C-terminal fragment mutants indicate that colicin
A unfolds on binding to its receptor [28] and calorimetric
measurements on colicin N indicate an exothermic structural
rearrangement upon binding to OmpF [17]. It has been pro-
posed that upon receptor binding, colicins N and A unfold
and that part of the polypeptide translocates through the pore
of OmpF [27,30]. The strongest evidence for this hypothesis
has been presented where a single OmpF mutation, G119D,
was identi¢ed as being colicin N resistant [30]. This mutation
is located on L3 deep in the OmpF pore and X-ray structural
analysis revealed that D119 was protruding into the channel
subdividing it into two sub-compartments [30]. It was also
shown that the mutation did not a¡ect the L-barrel structure
or the surface exposed loops.
Recently, in vivo ESR spectroscopy studies have shown
that the addition of colicin B a¡ected the mobility of a probe
on the gating loop of its receptor, FepA. As this loop controls
pore conductivity, it is proposed that the observed e¡ect was
due to the colicin polypeptide passing through the FepA pore,
which is likely to be much larger in diameter than OmpF [31].
Although a colicin unfolding step has been implicated in its
translocation across the outer membrane, work with disul-
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phide bonded colicin A P-domain helices [32] shows that the
translocation of this domain to the inner membrane is not
inhibited by the presence of the disulphide bonds. This pro-
vides strong evidence that the extensive unfolding of P-do-
main to allow it through the pore does not occur. On the
other hand, recent evidence has shown that colicin N T-do-
main, which interacts with Tol, is unstructured and this may
allow the T-domain to penetrate the OmpF pore [33,34]
However, the space available in the OmpF pore when L3 is
in the conformation determined by X-ray crystallography is
11U7 Aî compared to 11U19 Aî at the extracellular mouth of
the pore and 22U15 Aî at the periplasmic side [1]. Clearly a
polypeptide, which may contain secondary structural ele-
ments, will be unable to ¢t through the pore with L3 in place
(Fig. 1A,B). It therefore seems feasible that, to enable colicin
polypeptide translocation, L3 must adopt a di¡erent confor-
mation to create enough space in the pore. In view of this
possible involvement of L3 movement in colicin translocation,
we have used several OmpF cystine mutants (which form
disulphide bonds between two introduced cysteine residues
[35]), which restrict L3 to the conformation determined by
X-ray crystallography, to investigate L3 movement during
colicin activity in vivo using cell survival, in vivo K e¥ux
and £uorescence assays.
2. Materials and methods
2.1. Bacterial strains, plasmids and media
Production of plasmids which encode the OmpF cystine mutants
have previously been described [35]. Cystine mutants were chosen
from the lowest-energy pairs predicted by the SSBOND program
[36]. The porin de¢cient E. coli strain BZB1107 [30] was used to
express OmpF cystine mutants. Cells were grown in Luria-Bertani
(LB) broth with the addition of 10 mM DTT (Clelands reagent; DL-
dithiothreitol, Sigma) at 37‡C with shaking. Ampicillin was added as
required.
2.2. Protein puri¢cation
Colicin N was puri¢ed from E. coli BZB1019 (hsdR) carrying
pChap4 [15] as previously described [37]. Colicin A protein was sup-
plied by F. Pattus. Protein concentrations were determined by UV
absorption at 280 nm (using the extinction coe⁄cient of 49 500 M31
cm31 for colicin N).
2.3. Cell survival assays
Cell survival assays have been previously described [18,38^41].
BZB1107 cells expressing OmpF cystine mutants were grown in LB
broth with DTT to an OD600nm of 0.5. Cells were washed with 10 mM
oxidised DTT (trans-4,5-dihydroxy-1,2-dithiane, Sigma) in 100 mM
sodium phosphate bu¡er, pH 7.4 (bu¡er A) then resuspended in bu¡-
er A. 1 ml of cells (5U108 cells/ml) were incubated with colicin at 100
molecules/cell for 15 min at 37‡C. 18 ml of fresh LB was added and
the cells were grown at 37‡C for 2 h. Percentage survival was deter-
mined by the ratio of OD600nm of colicin treated to untreated cells.
Cells expressing OmpF single cysteine mutants were grown to an
OD600nm of 0.5 in LB. For normal cell survival conditions, cells
were washed in bu¡er A. For by-pass conditions [30,41,42], cells
were washed in 10 mM phosphate bu¡er pH 7.4 (bu¡er B). Assays
proceeded as for cystine mutants.
2.4. In vivo K e¥ux assays
Assays measuring K e¥ux resulting from colicin pore insertion
into the cytoplasmic membrane of sensitive E. coli have previously
been described [18,48]. Cells expressing OmpF cystine mutants were
grown to an OD600 of 0.75 in 10 mM DTT. Cells were resuspended in
0.2% glucose, 1 mM KCl and 10 mM oxidised DTT in Bu¡er A and
incubated at 37‡C for 15 min. Cells were washed in 10 mM oxidised
DTT in bu¡er A and resuspended in bu¡er A with 0.3% glucose, to a
concentration of 2U109 cells/ml. An aliquot of 10 ml of this suspen-
sion was used per assay with a colicin multiplicity of 1000, 400 or 100
molecules/cell added after 150 s. K e¥ux was measured using a K-
selective valinomycin electrode (BPS NICO). Total internal cellular
K concentrations were determined by heating a second aliquot of
cells to 75‡C for 30 min to release all internal K. Total internal K
values were used to calculate proportion of internal K remaining
over a time course of 1400 s.
2.5. In vivo £uorescent depolarisation assay
Cell sensitivity assays using membrane-potential sensitive £uores-
cent probes have previously been described [40,43,44]. As with the
cell survival assay, BZB1107 cells expressing OmpF mutants were
grown in LB broth with DTT at 10 mM to an OD600nm of 0.5. Cells
were washed with oxidised DTT at 10 mM in bu¡er A then resus-
pended in bu¡er A to a concentration of 5U109 cells/ml. Measure-
ments were made on an Aminco SLM 8100 spectro£uorometer at
25‡C with a 1 cm pathlength cuvette (Hellma). For each assay, 0.3
ml of cells were mixed with 2.7 ml of bu¡er A. In the spectro£uoro-
meter, 300 Wl of a 1 WM stock of ANS (8-anilino-1-naphthalene sul-
phonic acid, Sigma) was added to the cells after 50 s. After 200 s
colicin was added at a multiplicity of either 100 or 400 molecules/
cell. The £uorescence increase was monitored for at least 20 min.
2.6. Western blotting
To determine that the disulphide bonds had formed in vivo, cells
used in the K e¥ux assays were prepared for SDS-PAGE using non-
reducing and reducing conditions and run on 12% (w/v) acrylamide
gels. Samples were electroblotted onto nitrocellulose and after block-
ing with milk powder solution they were incubated with a rabbit
polyclonal antiserum raised against the OmpF sequence 236-NAT-
PITNKFTNTSGFANK-253. Blots were revealed using whole anti-
rabbit IgG linked to horseradish peroxidase (Sigma).
3. Results
3.1. Formation of disulphide bonds in vivo
Sites of the disulphide bonds used in this study are shown
together superimposed on the known structure of OmpF (Fig.
1C). Three of the disulphides are between L3 and barrel wall
(D107C-S177C, E117C-D312C and E117C-A333C) and two
are within L3 itself (V105C-F129C and Y124C-D127C). Pu-
ri¢ed mutant porins have been introduced into arti¢cial lipid
bilayers and their single channel conductances measured [35].
The single channel conductance of a wild-type OmpF channel
was measured at 827 pS. The mutant porins did show varia-
tions in single channel conductance, with channel sizes being
measured at between 694^875 pS. Hence the channel diameter
may be a¡ected by the introduced mutations.
Disulphide bond formation in vivo was analysed using
Western blotting. A previous study has shown that single
cysteine residues within the OmpC pore could not be labelled
without prior treatment with DTT [45]. This indicated that
some unknown component of growing cells can react with
these cysteine residues. In order to maximise disulphide
bond formation in OmpF double cysteine mutants, cells ex-
pressing these mutants were grown in DTT then washed with
oxidised DTT. Disulphide bond formation in vivo is evident
from the increased mobility of mutant OmpF polypeptide
when run under non-reducing conditions (Fig. 2). This may
be due to the restricted dimensions of the denatured molecule
[46]. However, for V105C-F129C, the disulphide bonded mu-
tant runs as native OmpF and the reduced form runs slower
than the native form. Interestingly, the L3 tip to barrel wall
mutants, E117C-D312C and E117C-A333C, appear not to
form disulphide bonds at the desired level in vivo under these
conditions. For the E117C-D312C mutant this is evident from
the lack of a faster migrating polypeptide and for E117C-
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A333C the presence of two polypeptides on the Western blot;
one running as wild-type and the other polypeptide migrating
faster than wild-type indicates only partial disulphide bond
formation. This was also observed in the puri¢ed protein,
which formed the desired disulphide bond at 80% e⁄ciency
[35]. The treatment of the cells with DTT/oxidised DTT thus
ensures the maximum disulphide bond formation in 3 of the
5 mutants. However we do not discount the possibility that
the E117C-D312C forms a disulphide bond as will be dis-
cussed in the next section. The Western blots also show that
the level of expression of wild-type and mutant OmpF are
similar.
3.2. Cell survival
Cell survival assays showed that only one OmpF cystine
mutant conferred resistance to colicins at 100 molecules/cell.
The mutant, D107C-S177C, caused a 52% cell survival rate
with colicin A at this multiplicity but a¡orded no protection
against colicin N. Cell survival assays using cells expressing
D107C and S177C single OmpF mutants revealed that resist-
ance to colicin A was due to the single mutation D107C. Cell
sensitivity returned to normal levels under by-pass conditions.
Surprisingly, we did not detect any survival of cells expressing
FEBS 20608 7-8-98
Fig. 3. Remaining internal K in cells expressing wild-type and mu-
tant OmpF after the addition of colicin. a: After the addition of
colicin N at 150 s to cells expressing wild-type OmpF at 100 mole-
cules per cell, K e¥ux was 1.5 nmol K/mg dry cell weight/s (A).
The only cystine mutant which caused resistance to colicin N at this
multiplicity was E117C-D312C which reduced K e¥ux to
0.85 nmol K/mg dry cell weight/s (B). b: K e¥ux from wild-type
cells was 0.49 nmol K/mg dry cell weight/s after the addition of
colicin A at 100 molecules per cell (A). None of the cells expressing
OmpF cystine mutants had any resistance to colicin A. The resist-
ance shown by cells expressing D107C-S177C, with a K e¥ux of
0.094 nmol K/mg dry cell weight/s, was due to the single mutation
D107C (B). Cells expressing the control colicin resistant mutant
R168C had a K e¥ux rate calculated at 0.01 nmol K/mg dry cell
weight/s (C).
Fig. 2. Electrophoretic migration of OmpF disulphide mutants in
vivo revealed using Western blotting. Protein in cells expressing
OmpF disulphide mutants were separated on a 12% polyacrylamide
gel under non-reducing (3DTT) and reducing (+DTT) conditions
and electroblotted onto nitrocellulose. OmpF mutants were revealed
using an antibody raised against the OmpF sequence 236-NAT-
PITNKFTNTSGFANK-253. Disulphide bond formation is evident
from the increased mobility of mutant OmpF polypeptide when run
under non-reducing conditions.
Fig. 1. OmpF molecular modelling. A: Molecular surface model
showing space available for translocation of poly-Ala through the
OmpF pore. Section through OmpF from the side showing a fully
extended poly-Ala in van der Waals representation. Model shows
limited space available at the ‘eyelet’ region for translocation of this
simple polypeptide model when L3 is in the conformation deter-
mined by X-ray crystallography. B: Same model as A but now
looking down through the pore from the cell surface but with
OmpF cell surface exposed loops removed. Models A and B show
that a colicin polypeptide would be unable to ¢t through the pore
unless L3 undergoes a large conformational shift. C: Cystine mu-
tants were chosen from the lowest-energy pairs predicted by the
SSBOND program [36]. Sites of the disulphide bonds are shown
superimposed on the known structure of OmpF and are: 1, V105C-
F129C; 2, D107C-S177C; 3, E117C-D312C; 4, E117C-A333C and
5, Y124C-D127C. D: OmpF model, as B but with L3 truncated to
residue 107. The model shows that more space is now available for
poly-Ala translocation but there is unlikely to be enough space
available for a colicin polypeptide which may contain secondary
structural elements.
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OmpF R168C, our control colicin N and A resistant mutant
[47], when colicin N was added at a multiplicity of 100 mol-
ecules/cell. When colicin A was added at the same multiplicity,
92% of the cells survived. Cell sensitivity, as with D107C,
returned under by-pass conditions.
3.3. K e¥ux measurements
Addition of colicin N to cells expressing the OmpF cystine
mutants always resulted in an e¥ux of cytoplasmic K. After
the addition of colicin N at 100 molecules/cell, K e¥ux from
cells expressing wild-type OmpF was rapid, with a rate of K
e¥ux of 1.5 nmol K/mg dry cell weight/s (calculated from
the linear part of the graph and assuming that 2U109 cells
correspond to 1 mg cell dry weight/ml, [48]). Cells expressing
the OmpF mutants V105C-F129C, D107C-S177C, E117C-
A333C and Y124C-D127C exhibited a K e¥ux at the
same rate as cells expressing wild-type OmpF. Cells expressing
the remaining mutant, E117C-D312, showed a reduction in
K e¥ux (Fig. 3a). The reduced rate was 0.85 nmol K/mg
dry cell weight/s and was not caused by the single OmpF
mutations E117C or D312C, which allowed wild-type K ef-
£ux from cells. This slight resistance was overcome when the
colicin N multiplicity was increased to 400 molecules per cell.
Evidence for the formation of a disulphide bond for this
mutant, which was not obvious from Western blot analysis,
comes from two observations. The reduced K e¥ux was not
seen in (i) cells expressing E117C-D312C which were not
treated with DTT/oxidised DTT and (ii) cells expressing the
single mutations E117C or D312C. Therefore we propose that
the disulphide bond for this mutant does form under treat-
ment conditions and that this does not cause a large increase
in the SDS-PAGE mobility of the denatured polypeptide. The
similar PhoE L3 ‘tip to barrel-wall’ cystine mutant, K18C-
E110C [49] which forms a disulphide bond at high e⁄ciency
also shows no di¡erence in mobility of the reduced and oxi-
dised form on normal SDS-PAGE gels.
Compared to colicin N, colicin A at 100 molecules per cell
caused a slightly lower K e¥ux with a rate of 0.49 nmol K/
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Fig. 5. Fluorescent depolarisation assay. Spectra show the change in
the £uorescence of the potential sensitive probe, ANS, caused by
membrane depolarisation after the addition of colicin after 200 s. a:
Fluorescence change in cells expressing wild-type OmpF after the
addition of colicin N at 100 molecules per cell (A). The only cystine
mutant which caused a deviation from wild-type £uorescence change
was E117C-D312C at 100 colicin N molecules per cell (B). b: None
of the cystine mutants caused a deviation from wild-type £uores-
cence change (A) at a colicin A multiplicity of 400 per cell. The de-
crease in £uorescence seen for D107C-S177C expressing cells was
due to the single mutation D107C (B). Our control mutant R168C
shows a large decrease in depolarisation (C).
Fig. 4. Remaining internal K in cells expressing D107C (a) and
R168C (b) at colicin A multiplicities of 100, 400 and 1000 per cell.
Increasing the multiplicity of colicin A from 100 to 1000 per cell in-
creased K. K e¥ux rates for cells expressing D107C were 0.09,
0.66 and 1.54 nmol K/mg dry cell weight/s and 0.01, 0.13 and
0.38 nmol K/mg dry cell weight/s for cells expressing R168C at
colicin A multiplicities of 100, 400 and 1000 per cell respectively.
Rates for cells expressing wild-type OmpF were 0.49, 1.54 and 2.99
nmol K/mg dry cell weight/s at the same multiplicities.
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mg dry cell weight/s for all cells expressing OmpF wild-type or
cystine mutants, except D107C-S177C. The reduced rate in
K e¥ux from cells expressing D107C-S177C, 0.094 nmol
K/mg dry cell weight/s, was, as with the cell sensitivity assay,
due to the single mutation D107C (Fig. 3b). This resistance
was reduced, but not overcome, when colicin A multiplicity
was increased to 400 and 1000 per cell (Fig. 4a).
3.4. Fluorescent depolarisation assay
The in vivo ANS £uorescence assay results were similar as
those from the K e¥ux assays. All cells expressing OmpF
cystine mutants were sensitive to colicin N to the same extent
as cells expressing wild-type OmpF at a multiplicity of 400
colicin molecules per cell. When the multiplicity was reduced
to 100 colicin N molecules per cell, cells expressing E117C-
D312C showed, as in K e¥ux assays, a slight resistance (Fig.
5a). When colicin A was used, again, resistance was seen for
the D107C expressing cells (Fig. 5b) but no resistance was
established for OmpF cystine mutant expressing cells.
We could not detect any colicin N resistance in cells ex-
pressing OmpF R168C at multiplicities of 100, 400 and 1000
molecules per cell using both the K e¥ux and £uorescence
assays. However a resistance to colicin A was established us-
ing both assay systems (Fig. 3bFig. 5b). K e¥ux rates at 100,
400 and 1000 colicin A molecules per cell are shown (Fig. 4b).
Since we have been able to use our K e¥ux assay to detect
very small changes in sensitivity, we must conclude that in
spite of published data to the contrary [47] the OmpF
R168C mutant does not cause resistance to colicin N and
must be referred to as a colicin A resistant mutant only.
4. Discussion
Using cystine scanning mutagenesis of OmpF L3, we have
attempted to answer the question whether colicins N and A
translocate across the outer membrane of E. coli through the
pore of OmpF. It is clear that for a polypeptide to translocate
through the pore, the internal L3 must undergo a conforma-
tional change to create enough space within the pore. We have
demonstrated that for four of our OmpF double cysteine mu-
tants, V105C-F129C, D107C-S177C, E117C-D312C and
Y124C-D127C, we can maximise the formation of the disul-
phide bond in vivo by treatment of the cells with DTT/oxi-
dised DTT, thereby ¢xing L3 in the conformation determined
by X-ray crystallography [1]. The ¢fth mutant, E117C-A333C,
formed a disulphide bond at much reduced levels in vivo. A
mixed population of bonded and unbonded porin was present
in our experiments and it was to be expected that cells ex-
pressing this mutant had a K e¥ux the same as cells express-
ing wild-type OmpF.
L3 movement has previously been implicated in porin volt-
age gating. It has now been shown that this is not the case
[35,50,51]. Single channel conductance measurements on wild-
type OmpF presumably relate to a channel size with L3 in the
conformation determined by X-ray crystallography. By com-
paring single channel conductances of our OmpF cystine mu-
tants to the value for wild-type OmpF, we conclude that
although channel sizes vary, no major changes were seen in
the size of the mutant channels [35].
The unique resistance to colicin N by cells expressing the
mutant E117C-D312C at a colicin multiplicity of 100 per cell
after treatment of the cells with DTT/oxidised DTT may in-
dicate that small conformational changes are needed at the tip
of L3 for full activity of colicin N. Since cell sensitivity re-
turned when the multiplicity of toxin increased, this resistance
is probably due to impeded binding of colicin N to OmpF.
The colicin N resistant OmpF mutation, G119D [30], which is
two residues from the tip of L3, caused a distortion of L3 and
reduced receptor binding. This implies that, for colicin N
activity, L3 needs to be either in a de¢ned conformation
which is distorted by mutation or that it needs £exibility.
However, we cannot be con¢dent that the mutant E117C-
D312C forms a disulphide bond at 100% e⁄ciency and there-
fore must explore the possibility that the tip of L3, from
residue 107, where we have produced a disulphide bond at
100%, may undergo a conformational shift. Examination of
a truncated OmpF L3 model (Fig. 1D), with the tip of the
loop being residue 107 rather than 117, reveals more space
available for poly-Ala translocation but it still remains im-
probable that a partially unfolded colicin polypeptide, which
may contain some secondary structural elements as well as
bulky sidechains, is able to translocate through this model
pore. Therefore a possibility exists that an unstructured T-
domain may penetrate the pore in order to bind to tol A
[29,33] but since the tol A binding site is distant from the
N-terminus this would require the translocation of 65 residues
including two tryptophans [34].
The formation of OmpF disulphide bonds had no e¡ect on
the activity of colicin A. Although the single mutation, D107C
and our control mutant, R168C, conferred resistance to col-
icin A, cell survival assays carried out under by-pass condi-
tions restored cell sensitivity for both mutants. This suggests
that the mutations D107C and R168C are required for colicin
A receptor binding only.
The results here demonstrate that the formation of disul-
phide bonds between L3 and the barrel wall and within L3
itself, at various positions along L3, had little e¡ect on colicin
N and A activities on cells expressing these mutants in vivo.
With L3 ¢xed in the conformation determined by X-ray crys-
tallography not enough space is available for the translocation
of a folded polypeptide. DucheŁ et al. [32] showed that disul-
phide bonds which ¢xed the folded conformation of colicin A
also had no e¡ect upon translocation. Thus from two di¡erent
uses of disulphide bond technology we must conclude that the
whole colicin molecule does not translocate through the pore
of OmpF. Our results further imply that, since the single
mutations D107C and R168C have no e¡ect on colicin N,
colicins N and A may interact with OmpF at di¡erent recep-
tor sites. However, the reason for the receptor binding resist-
ance shown by D107C to colicin A remains intriguing since
this mutation is located deep in the OmpF pore on the peri-
plasmic side of L3.
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